These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16483549)

  • 1. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
    Kiefer F; Jahn H; Otte C; Naber D; Wiedemann K
    Biol Psychiatry; 2006 Jul; 60(1):74-6. PubMed ID: 16483549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.
    King AC; Schluger J; Gunduz M; Borg L; Perret G; Ho A; Kreek MJ
    Neuropsychopharmacology; 2002 Jun; 26(6):778-88. PubMed ID: 12007748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.
    Hammarberg A; Nylander I; Zhou Q; Jayaram-Lindström N; Reid MS; Franck J
    Brain Res; 2009 Dec; 1305 Suppl():S2-6. PubMed ID: 19799882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study.
    Farren CK; O'Malley S; Grebski G; Maniar S; Porter M; Kreek MJ
    Alcohol Clin Exp Res; 1999 Mar; 23(3):502-8. PubMed ID: 10195825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
    Kiefer F; Jahn H; Otte C; Demiralay C; Wolf K; Wiedemann K
    J Psychiatr Res; 2005 Sep; 39(5):545-51. PubMed ID: 15992564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.
    Zimmerman U; Spring K; Koller G; Holsboer F; Soyka M
    Pharmacopsychiatry; 2004 May; 37(3):98-102. PubMed ID: 15179967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
    Snyder JL; Bowers TG
    Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.
    Ooteman W; Koeter MW; Verheul R; Schippers GM; van den Brink W
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):558-66. PubMed ID: 17379484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment.
    Kiefer F; Jahn H; Wiedemann K
    Pharmacopsychiatry; 2005 Jul; 38(4):184-6. PubMed ID: 16025425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute HPA axis response to naltrexone differs in female vs. male smokers.
    Roche DJ; Childs E; Epstein AM; King AC
    Psychoneuroendocrinology; 2010 May; 35(4):596-606. PubMed ID: 19837518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenal axis response to oral naltrexone in alcoholics during early withdrawal.
    Besirli A; Eşel E; Özsoy S; Turan T
    Pharmacopsychiatry; 2014 Jul; 47(4-5):151-5. PubMed ID: 24936803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
    Schluger JH; Ho A; Borg L; Porter M; Maniar S; Gunduz M; Perret G; King A; Kreek MJ
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender.
    Gianoulakis C; Dai X; Brown T
    Alcohol Clin Exp Res; 2003 Mar; 27(3):410-23. PubMed ID: 12658106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acamprosate and naltrexone: similar efficacy for relapse].
    Saitz R
    Rev Med Suisse; 2014 Dec; 10(455):2437. PubMed ID: 25752019
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypothalamic-Pituitary-Adrenocortical Axis Activity in Alcohol-Dependent Patients During Treatment with High-Dose Baclofen.
    Geisel O; Schlemm L; Hellweg R; Wiedemann K; Müller CA
    Pharmacopsychiatry; 2019 Jan; 52(1):32-37. PubMed ID: 29359279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.